Stocklytics Platform
Asset logo for symbol XRAY
DENTSPLY SIRONA
XRAY51
$18.90arrow_drop_down0.23%-$0.04
Asset logo for symbol XRAY
XRAY51

$18.90

arrow_drop_down0.23%
Key Stats
Open$18.92
Prev. Close$18.95
EPS-2.03
Next Earnings DateJan 10, 2025
PE Ratio-
LOWHIGH
Day Range18.71
18.97
52 Week Range17.22
37.60
Ratios
Revenue-
EPS-2.03
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay dateJan 10, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

XRAY-
US Healthcare Sector-
US Market-
warning

XRAY / Market

XRAY lose to the US Market which returned 1.00% over the last twenty four hours.
warning

XRAY / Healthcare Sector

XRAY lose to the US Healthcare sector which returned 2.95% over the last twenty four hours.

DENTSPLY SIRONA (XRAY) Statistics

DENTSPLY SIRONA Inc (XRAY) is a leading global provider of dental solutions. The company specializes in developing and manufacturing a wide range of innovative products and technologies for the dental industry. With a strong focus on research and development, DENTSPLY SIRONA Inc is committed to delivering high-quality products that meet the evolving needs of dental professionals and their patients.
When it comes to stock statistics, DENTSPLY SIRONA Inc has shown a strong performance in recent years. The company's stock, ticker symbol XRAY, has consistently outperformed the broader market and its sector. This can be attributed to a combination of factors, including solid financial fundamentals and strong revenue growth. XRAY's stock valuation metrics also indicate that it is currently trading at an attractive price, making it a potentially lucrative investment opportunity.
add DENTSPLY SIRONA  to watchlist

Keep an eye on DENTSPLY SIRONA

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has DENTSPLY SIRONA (XRAY) stock's performance compared to its sector and the market over the past year?

Over the past year, DENTSPLY SIRONA (XRAY) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.34%, DENTSPLY SIRONA has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.67%, it has fallen short of the market average. This comparison highlights DENTSPLY SIRONA 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of DENTSPLY SIRONA (XRAY) stock?

The PE ratio for DENTSPLY SIRONA (XRAY) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of DENTSPLY SIRONA (XRAY) stock?

The Earnings Per Share (EPS) for DENTSPLY SIRONA (XRAY), calculated on a diluted basis, is -$2.03. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of DENTSPLY SIRONA (XRAY) stock?

The operating margin for DENTSPLY SIRONA (XRAY) is 6.94%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of DENTSPLY SIRONA (XRAY) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of DENTSPLY SIRONA (XRAY) is $592M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does DENTSPLY SIRONA (XRAY) have?

DENTSPLY SIRONA (XRAY) has a total debt of $2.34B. The net debt, which accounts for cash and cash equivalents against the total debt, is $2.02B.

Take Your Investments to a Whole New Level